Onco-Nephrology: Renal Toxicities of Chemotherapeutic Agents

被引:208
作者
Perazella, Mark A. [1 ]
机构
[1] Yale Univ, Dept Med, Nephrol Sect, New Haven, CT 06520 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2012年 / 7卷 / 10期
关键词
CISPLATIN NEPHROTOXICITY; KIDNEY; CETUXIMAB; CANCER; HYPOMAGNESEMIA; APOPTOSIS; THERAPY; FAILURE; ALPHA; VEGF;
D O I
10.2215/CJN.02780312
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Despite dramatic improvements in patient survival and drug tolerability, nephrotoxicity remains an important complication of chemotherapy. Adverse renal effects occur because of innate drug toxicity and a number of patient- and drug-related factors. To provide cutting edge care for these patients, nephrologists and oncologists must be familiar with the nephrotoxicity of these drugs, particularly their associated clinical and laboratory manifestations. Rapid diagnosis, targeted treatment, and supportive care are critical to improving care for these patients. Unfortunately, some patients who develop nephrotoxicity will be left with long-term complications such as chronic tubulopathies and CKD. Onco-Nephrology is a new area that is rapidly expanding and requires a close working relationship between oncologists and nephrologists. Clin J Am Soc Nephrol 7: 1713-1721, 2012. doi: 10.2215/CJN.02780312
引用
收藏
页码:1713 / 1721
页数:9
相关论文
共 45 条
[1]   Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity [J].
Aleksa, K ;
Matsell, D ;
Krausz, K ;
Gelboin, H ;
Ito, S ;
Koren, G .
PEDIATRIC NEPHROLOGY, 2005, 20 (07) :872-885
[2]   Meta-Analysis of Incidence and Risk of Hypomagnesemia with Cetuximab for Advanced Cancer [J].
Cao, Yunfei ;
Liao, Cun ;
Tan, Aihua ;
Liu, Lidan ;
Gao, Feng .
CHEMOTHERAPY, 2010, 56 (06) :459-465
[3]   Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2 [J].
Ciarimboli, G ;
Ludwig, T ;
Lang, DF ;
Pavenstädt, H ;
Koepsell, H ;
Piechota, HJ ;
Haier, J ;
Jaehde, U ;
Zisowsky, J ;
Schlatter, E .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 167 (06) :1477-1484
[4]   Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation [J].
Ciarimboli, G ;
Koepsell, H ;
Iordanova, M ;
Gorboulev, V ;
Dürner, B ;
Lang, D ;
Edemir, B ;
Schröter, R ;
Van Le, T ;
Schlatter, E .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (06) :1562-1570
[5]   New Clues for Nephrotoxicity Induced by Ifosfamide: Preferential Renal Uptake via the Human Organic Cation Transporter 2 [J].
Ciarimboli, Giuliano ;
Holle, Svenja Kristina ;
Vollenbroecker, Beate ;
Hagos, Yohannes ;
Reuter, Stefan ;
Burckhardt, Gerhard ;
Bierer, Stefan ;
Herrmann, Edwin ;
Pavenstaedt, Hermann ;
Rossi, Rainer ;
Kleta, Robert ;
Schlatter, Eberhard .
MOLECULAR PHARMACEUTICS, 2011, 8 (01) :270-279
[6]   Interferon α sensitisation induced fatal renal insufficiency in a patient with chronic myeloid leukaemia:: case report and review of literature [J].
Colovic, M. ;
Jurisic, V. ;
Jankovic, G. ;
Jovanovic, D. ;
Nikolic, L. J. ;
Dimitrijevic, J. .
JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (08) :879-881
[7]  
Cummings B.S., 2001, Diseases of the Kidney and Urinary Tract, P1071
[8]   Renal toxicities of chemotherapy [J].
de Jonge, MJA ;
Verweij, J .
SEMINARS IN ONCOLOGY, 2006, 33 (01) :68-73
[9]   Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients [J].
De Stefano, Alfonso ;
Carlomagno, Chiara ;
Pepe, Stefano ;
Bianco, Roberto ;
De Placido, Sabino .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (05) :1207-1213
[10]   Renal TRPathies [J].
Dietrich, Alexander ;
Chubanov, Vladimir ;
Gudermann, Thomas .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (05) :736-744